Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
21-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #35036
advertisement
Schmetterer L
30
Showing records 1 to 25 |
Display all abstracts from
Schmetterer L
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Chua J
Ophthalmology. Glaucoma
2020; 3: 314-326
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Kadziauskienė A
Journal of Glaucoma
2020; 29: 648-655
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
G Konstas A; Schmetterer L
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Chua J
Journal of Glaucoma
2020; 29: 648-655
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Tan B
Ophthalmology. Glaucoma
2020; 3: 314-326
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Baskaran M
Journal of Glaucoma
2020; 29: 648-655
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Ke M
Ophthalmology. Glaucoma
2020; 3: 314-326
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Costa VP
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Yow AP
Journal of Glaucoma
2020; 29: 648-655
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Holló G
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Schwarzhans F
Ophthalmology. Glaucoma
2020; 3: 314-326
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Katsanos A
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Vass C
Ophthalmology. Glaucoma
2020; 3: 314-326
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Tan B
Journal of Glaucoma
2020; 29: 648-655
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Denis P
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Sng C
Journal of Glaucoma
2020; 29: 648-655
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Wong D; Nongpiur ME
Ophthalmology. Glaucoma
2020; 3: 314-326
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Ašoklis R
Journal of Glaucoma
2020; 29: 648-655
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Quaranta L
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Lesinskas E
Journal of Glaucoma
2020; 29: 648-655
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Wei Chua MC
Ophthalmology. Glaucoma
2020; 3: 314-326
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Irkec M; Castejón MA
Expert Opinion on Drug Safety
2020; 19: 1445-1460
90077
Association Between Structure-function Characteristics and Visual Field Outcomes in Glaucoma Subjects With Intraocular Pressure Reduction After Trabeculectomy
Crowston J
Journal of Glaucoma
2020; 29: 648-655
90112
Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma
Yao X; Cheng CY
Ophthalmology. Glaucoma
2020; 3: 314-326
90450
Current and emerging fixed combination therapies in glaucoma: a safety and tolerability review
Teus MA
Expert Opinion on Drug Safety
2020; 19: 1445-1460
«
1
2
»
Issue
21-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement